53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2593-2600

  Li, Xiaoyan ^a   Xu, Bing ^b   Moran, Meena S ^c   Zhao, Yuhan ^a   Su, Peng ^a   Haffty, Bruce G ^d   Shao, Changshun ^b   Yang, Qifeng ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong University   (China)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 146A; P53 BINDING PROTEIN 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NF-KAPPA B; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 84870367600     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs298     Document Type: Article

References (33)

1. Siegel, R. et al. (2012) Cancer statistics, 2012. CA. Cancer J. Clin., 62, 10-29.
2. Iwabuchi, K. et al. (1994) Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl. Acad. Sci. U.S.A., 91, 6098-6102.
3. Iwabuchi, K. et al. (1998) Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J. Biol. Chem., 273, 26061-26068.
4. Anderson, L. et al. (2001) Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol. Cell. Biol., 21, 1719-1729.
5. Schultz, L.B. et al. (2000) p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol., 151, 1381-1390.
6. Xia, Z. et al. (2001) Negative cell cycle regulation and DNA damageinducible phosphorylation of the BRCT protein 53BP1. J. Biol. Chem., 276, 2708-2718.
7. DiTullio, R.A. Jr et al. (2002) 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol., 4, 998-1002.
8. Fernandez-Capetillo, O. et al. (2002) DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol., 4, 993-997.
9. Wang, B. et al. (2002) 53BP1, a mediator of the DNA damage checkpoint. Science, 298, 1435-1438.
10. Ward, I.M. et al. (2005) 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice. Mol. Cell. Biol., 25, 10079-10086.
11. Morales, J.C. et al. (2006) 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. Proc. Natl. Acad. Sci. U.S.A., 103, 3310-3315.
12. Bouwman, P. et al. (2010) 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat. Struct. Mol. Biol., 17, 688-695.
13. Haffty, B.G. et al. (2011) Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). Int. J. Radiat. Oncol. Biol. Phys., 80, 385-391.
14. Hu, G. et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell, 15, 9-20.
15. Li, X. et al. (2011) Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci., 102, 1151-1157.
16. Dimitrova, N. et al. (2008) 53BP1 promotes non-homologous end joining of telomeres by increasing chromatin mobility. Nature, 456, 524-528.
17. Su, P. et al. (2010) Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue. Diagn. Pathol., 5, 38.
18. Sovak, M.A. et al. (1997) Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100, 2952-2960.
19. Dejardin, E. et al. (1995) Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene, 11, 1835-1841.
20. Rayet, B. et al. (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene, 18, 6938-6947.
21. Bist, P. et al. (2011) Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis. Oncogene, 30, 3174-3185.
22. Shibata, A. et al. (2002) Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res. Treat., 73, 237-243.
23. Végran, F. et al. (2011) Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res., 71, 2550-2560.
24. Ambros, V. (2004) The functions of animal microRNAs. Nature, 431, 350-355.
25. Gregory, R.I. et al. (2005) MicroRNA biogenesis and cancer. Cancer Res., 65, 3509-3512.
26. Calin, G.A. et al. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer, 6, 857-866.
27. Esquela-Kerscher, A. et al. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
28. Bhaumik, D. et al. (2008) Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene, 27, 5643-5647.
29. Jiang, L. et al. (2012) MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J. Clin. Invest., 122, 33-47.
30. Hurst, D.R. et al. (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res., 69, 1279-1283.
31. Wakai, T. et al. (2011) Alteration of p53-binding protein 1 expression as a risk factor for local recurrence in patients undergoing resection for extrahepatic cholangiocarcinoma. Int. J. Oncol., 38, 1227-1236.
32. Hong, S. et al. (2012) 53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway. Oncol. Rep., 27, 1251-1257.
33. Paik, J.H. et al. (2011) MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin. Cancer Res., 17, 4761-4771.